[1] William B, Julia W. Acute liver failure. New Engl J Med,2013,369:2525-2534. [2] Ramesh K, Vikram B, Shankar K, et al. Antituberculosis therapy-induced acute liver failure: magnitude, profile, prognosis, and predictors of outcome. Hepatology, 2010, 51:1665-1674. [3] Angels E, Antoni M, de Manuel LM. Acute liver failure in Spain: analysis of 267 cases. Liver Transplant, 2007, 13:1389-1395. [4] Bower WA, Johns M, Margolis HS, et al. Population-based surveillance for acute liver failure. Am J Gastroenterol, 2007, 102:2459-2463. [5] Kim SJ, Lee SM. NLRP3 inflammasome activation in d-galactosamine and lipopolysaccharide-induced acute liver failure: role of heme oxygenase-1. FreeRad Biol Med, 2013, 65:997-1004. [6] Guo H, Callaway JB., Ting JPY. Inflammasomes: mechanism of action, role in disease, and therapeutics. Nature Med, 2015, 21:677-687. [7] Pietras EM. Inflammation: a key regulator of hematopoietic stem cell fate in health and disease. Blood, 2017, 130:1693-1698. [8] Prame KK, Nicholls AJ, Wong CHY. Partners in crime: neutrophils and monocytes/macrophages in inflammation and disease. Cell Tiss Res, 2018, 371:551-565. [9] Wu ZG, Han MF, Chen T, et al.Acute liver failure: mechanisms of immune-mediated liver injury. Liver Int, 2010, 30(6):782-794. [10] Possamai LA, Thursz MR, Wendon Julia A, et al. Modulation of monocyte/macrophage function: a therapeutic strategy in the treatment of acute liver failure. J Hepatol, 2014, 61:439-445. [11] Peng JJ, Li JC, Huang J, et al. p300/CBP inhibitor A-485 alleviates acute liver injury by regulating macrophage activation and polarization. Theranostics, 2019, 9:8344-8361. [12] Strowig T, Henao MJ, Elinav E, et al. Inflammasomes in health and disease. Nature, 2012, 481:278-286. [13] Evangelos T, Oltin TP, Lucia AP,et al. MerTK expressing hepatic macrophages promote the resolution of inflammation in acute liver failure. Gut, 2018, 67(2):333-347. [14] Meng S, Zhang L, Tang Y, et al. BET inhibitor JQ1 blocks inflammation and bone destruction. J Dent Res, 2014, 93:657-662. [15] Belkina AC, Nikolajczyk BS, Denis GV. BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses. J Immunol, 2013, 190(7):3670-3678. [16] Rudman MD, Choi JS, Lee HE, et al. Bromodomain and extraterminal domain-containing protein inhibition attenuates acute inflammation after spinal cord injury. Exp Neurol, 2018, 309:181-192. [17] Park SY, Bae YS, Ko MJ, et al. Comparison of anti-inflammatory potential of four different dibenzo cyclooctadiene lignans in microglia; action via activation of PKA and Nrf-2 signaling and inhibition of MAPK/STAT/NF-κB pathways. Mol Nutr Food Res, 2014, 58:738-748. [18] Zhang F, Zhong RJ, Li S, et al. Acute hypoxia induced an imbalanced M1/M2 activation of microglia through NF-κB signaling in Alzheimer's disease mice and wild-type littermates. Front Aging Neurosci, 2017, 9:282. |